Robert Gabbay

Company: Harvard University

Job title: Chief Medical Officer & Senior Vice President at Joslin Diabetes Center & Associate Professor of Medicine

Seminars:

Panel Discussion: Considering the Future of Obesity Therapeutics: Beyond Appetite Suppression for More Varied Treatment Options 3:30 pm

Discussing the limitations of current therapies that primarily focus on appetite suppression Exploring new targets and delving into emerging areas of research, such as targeting metabolic pathways, gut microbiota modulation, and precision medicine approaches Exploring the potential of combining different therapies and modalities to achieve more comprehensive and sustainable weight lossRead more

day: Day Two

Redefining Obesity & the Implications for Drug Development in the PostLancet Commission Era to Improve Patient Treatment for More Effective Weight Management 8:30 am

Redefining obesity beyond BMI, emphasizing health outcomes and moving towards a more personalized approach based on the Lancet Commission on Obesity’s recommendations Prioritizing targets that address the underlying causes of clinical obesity and its complications, developing personalized therapies, and emphasizing clinical endpoints that reflect improved health outcomes Understanding the challenges of implementing this new approach,…Read more

day: Day One